Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Singlera Logo
Singlera Growth Score
85
CB Rank
74571
Heat Score
52
Singlera is a medical firm that is working to overcome the delay in early diagnosis of cancer through screening and auxiliary.
Founded
obfuscation
PrivateVenture - Series Unknown Pudong, Shandong, China11-50 www.singlera.com.cn/
Health Care
Health Diagnostics
Medical
Product Research
Overview

Singlera
Total Funding
obfuscation
Growth Score
85
Heat Score
52

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score85
-4 pts
in past quarter
Heat Score 52
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Singlera

CB Rank
74571
Singlera is a medical firm that is working to overcome the delay in early diagnosis of cancer through screening and auxiliary.
Founded
obfuscation
PrivateVenture - Series Unknown Pudong, Shandong, China11-50 www.singlera.com.cn/
Health Care
Health Diagnostics
Medical
Product Research

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series B
OBF
in
obfuscation

Details

Legal Name Shanghai Kunyuan Biotechnology Co., Ltd.
Also Known As Shanghai Kunyuan Biotechnology, Kanyuan Biotechnology, Xunyuan Biotechnology, 鹍远生物, Xunyuan Biotech
Operating Status Active
Company Type For Profit
Phone Number 400-9204-888
Contact Email info@singleragenomics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ColonAiQ 常艾克®
A blood-based multi-gene methylation detection kit for early screening of colorectal cancer.
PanSeer®
A circulating tumor DNA (ctDNA) methylation-based pan-cancer early screening technology.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Singlera Logo
Venture Round - Singlera
5
obfuscation
— Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Guangling Guotou Logo
Guangling Guotou
—
Venture Round - Singlera Logo
Venture Round - Singlera
—
Guangling Guotou Logo
Guangling Guotou
—
Venture Round - Singlera Logo
Venture Round - Singlera
—
Guangling Guotou Logo
Guangling Guotou
—
Venture Round - Singlera Logo
Venture Round - Singlera
—
Guangling Guotou Logo
Guangling Guotou
—
Venture Round - Singlera Logo
Venture Round - Singlera
—
Guangling Guotou Logo
Guangling Guotou
—
Venture Round - Singlera Logo
Venture Round - Singlera
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

Active Website Tech Count

3Singlera is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Baidu Maps.

Total IP

18Singlera has registered 18 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Singlera's headquarters? Singlera is located in Pudong, Shandong, China.Who invested in Singlera? Singlera has 17 investors including Guangling Guotou and  Economic Development Investment.When was the last funding round for Singlera? Singlera closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Singlera's competitors? Alternatives and possible competitors to Singlera may include Freenome, SOPHiA GENETICS, and  23andMe.How much funding has Singlera raised to date? Singlera has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|